Document is current
Any future updates will be listed below
-
Authors
Zietse, Michiel https://orcid.org/0009-0002-1497-3033
van der Zeeuw, Shannon L.
Gebbink, Anne-Sophie Klein
de Vries, Annemarie C.
Crombag, Marie-Rose B. S.
van Leeuwen, Roelof W. F.
Hoedemakers, Maaike J.
- License Information
-
More Information
Article History
Accepted: 28 November 2024
First Online: 19 December 2024
Declarations
:
: This article was not supported by external funding.
: Annemarie C. de Vries has served on advisory boards for Takeda, Janssen, Bristol Myers Squibb, Abbvie, Pfizer, Lilly, and Galapagos and has received unrestricted research grants from Takeda, Janssen, Dr Falk, and Pfizer outside the submitted work. Roelof W.F. van Leeuwen reports research grants (all paid to the institution) from Bristol Myers Squibb, Pfizer, consulting fees from Bristol Myers Squibb, Roche, Pierre Fabre, AstraZeneca, Pfizer, Novartis, and Eli Lilly, speaker fees from AstraZeneca, and travel support from Ipsen, all outside the submitted work. Michiel Zietse, Shannon L. van der Zeeuw, Anne-Sophie Klein Gebbink, Marie-Rose B.S. Crombag, and Maaike J. Hoedemakers have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: The data generated during the current study are available in the text and ESM. Further data can be made available from the corresponding author on reasonable request.
: Not applicable.
: MBSC, RWFL, and MJH conceptualized and designed this study. SZ, MBSC, RWFL, and MJH contributed to the data collection, MZ, SZ, MBSC, RWFL, and MJH contributed to the analysis. MZ, SZ, MBSC, RWFL, and MJH reviewed the available data. MZ, SZ, ASKG, ACV, MBSC, RWFL, and MJH drafted the manuscript. All authors read, commented, and approved the final manuscript, prior to submission.
